Trial intelligence / Profile preview

Coagulation effect of four common plasma volume expanders in total hip replacement surgery

2007-000729-24Phase 4Completed

Sponsor
University Hospital, Linköping
Start
Feb 2007
Modality
Biodegradable Polymers → Polymer-based Nanoparticles → Nanoparticles → Drug Delivery Systems, Non-biodegradable Polymers → Polymer-based Nanoparticles → Nanoparticles → Drug Delivery Systems, Injectable Hydrogels → Hydrogel Systems → Drug Delivery Systems
Countries
1
01

Overview

Phase 4, randomised trial of dextran, Volulyte, hydroxyethyl starch 130/0.42 and hetastarch in None and Bleeding (4 arms), sponsored by University Hospital, Linköping. Started Feb 2007; status: completed.

02

Drugs

dextranVolulytehydroxyethyl starch 130/0.42hetastarch
03

Conditions

Bleeding

Beyond the preview

Go deeper on 2007-000729-24.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2007-000729-24.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call